![Kenneth Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Kenneth S.
Lin was the founder of Ab Initio Biotherapeutics, Inc. (2015) and served as President & Chief Executive Officer from 2015 to 2019.
Current jobs include Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and Advisor at Tarrant Capital IP LLC since 2008.
Former jobs include Director at Vibrynt, Inc., Director at Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC, Associate at Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Education includes an undergraduate degree from Stanford University (1994) and a doctorate from Case Western Reserve University (1999).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/09/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/02/2021 |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Operates as an alternative asset management firm | Corporate Officer/Principal | 13/06/2012 |
| Empresas | Cargo | Fin |
|---|---|---|
Ab Initio Biotherapeutics, Inc.
 Ab Initio Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company | Director Ejecutivo | 01/07/2019 |
Ulthera, Inc.
 Ulthera, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Contacto de Relaciones con Inversores | 01/07/2014 |
| TPG INC. | Corporate Officer/Principal | 01/06/2012 |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Corporate Officer/Principal | 31/12/2007 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2002 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Ulthera, Inc.
Ulthera, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
Vibrynt, Inc.
 Vibrynt, Inc. Medical SpecialtiesHealth Technology Develops medical devices for obesity treatment | Health Technology |
Conventus Orthopaedics, Inc.
 Conventus Orthopaedics, Inc. Medical/Nursing ServicesHealth Services Provides orthopedic surgical solutions, including sterile-packaged implants and instrument kits for foot, ankle and extremity surgeries | Health Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Finance |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Finance |
Tarrant Capital IP LLC
Tarrant Capital IP LLC Investment ManagersFinance Operates as an alternative asset management firm | Finance |
Ab Initio Biotherapeutics, Inc.
Ab Initio Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company | Health Technology |
Anebulo Pharmaceuticals, Inc.
 Anebulo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
TPG, Inc.
 TPG, Inc. Investment ManagersFinance Operates as a alternative asset manager | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
